In the latest trading session, 0.75 million Medtronic Plc (NYSE:MDT) shares changed hands as the company’s beta touched 0.85. With the company’s most recent per share price at $90.92 changed hands at -$0.2 or -0.22% at last look, the market valuation stands at $116.60B. MDT’s current price is a discount, trading about -1.46% off its 52-week high of $92.25. The share price had its 52-week low at $68.84, which suggests the last value was 24.29% up since then. When we look at Medtronic Plc’s average trading volume, we note the 10-day average is 4.38 million shares, with the 3-month average coming to 6.01 million.

Analysts gave the Medtronic Plc (MDT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.32. If we narrow down to specifics, the data shows that 1 out of 15 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 7 recommended MDT as a Hold, 7 felt it is a Buy and 0 rated the stock as Underweight. Medtronic Plc’s EPS for the current quarter is expected to be 1.25.

Medtronic Plc (NYSE:MDT) trade information

Instantly MDT was in red as seen in intraday trades today. With action 1.03%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 10.37%, with the 5-day performance at 1.03% in the green. However, in the 30-day time frame, Medtronic Plc (NYSE:MDT) is 1.29% up. Looking at the short shares, we see there were 10.67 million shares sold at short interest cover period of 1.44 days.

The consensus price target for the stock as assigned by Wall Street analysts is 104, meaning bulls need an upside of 12.58% from its recent market value. According to analyst projections, MDT’s forecast low is 80 with 165 as the target high. To hit the forecast high, the stock’s price needs a -81.48% plunge from its current level, while the stock would need to tank 12.01% for it to hit the projected low.

Medtronic Plc (MDT) estimates and forecasts

Data shows that the Medtronic Plc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 13.11% over the past 6 months, a 4.62% in annual growth rate that is considerably lower than the industry average of 11.50%. Year-over-year growth is forecast to reach 3.90% up from the last financial year.

Consensus estimates given by 25 financial analysts project the company’s revenue in the current quarter to hit an average of 8.27B. 25 analysts are of the opinion that Medtronic Plc’s revenue for the current quarter will be 8.41B.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -4.12%. The 2024 estimates are for Medtronic Plc earnings to increase by 4.88%, but the outlook for the next 5-year period is at 5.00% per year.

MDT Dividends

Medtronic Plc is expected to release its next quarterly earnings report on 2024-Nov-19. The 3.06% annual yield figure for the share gives it an annual dividend of 2.78. It is important to note, however, that the 3.06% dividend yield ratio should serve as a guide only, as you should also take into consideration many other aspects of a company’s operations and fundamentals before making any investment decision. During the past 5 years, the average dividend yield was 2.63 per year.

Medtronic Plc (NYSE:MDT)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 0.26% of Medtronic Plc shares while 85.75% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 85.97%. There are 85.75% institutions holding the Medtronic Plc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 9.5358% of the shares, roughly 126.61 million MDT shares worth $9.97 billion.

BLACKROCK INC. holds the second largest percentage of outstanding shares, with 8.4275% or 111.89 million shares worth $8.81 billion as of 2024-06-30.